Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT02878694
Eligibility Criteria:
Inclusion Criteria:
* Male or female ( with suitable contraception) over 18 years of age 75
* OPMD confirmed by genetic diagnosis ( gene mutation PABPN1 by triplet expansion GCG)
* OPMD with ptosis
* Obtaining informed consent signed
Exclusion Criteria:
* Evolutionary contagious infectious pathology
* Inflammatory diseases
* Any other neuromuscular disease
* Malignant tumor pathology of history
* Renal impairment ( creatinine clearance \< 60ml / min)
* Hepatic insufficiency
* Pregnant woman confirmed by a dosing B-HCG or lactating
* Inability to perform a muscle biopsy
* Preparation of myoblasts uncommitted to step 2nd release
* Inability to follow up to 36 months
* Refusal to sign the consent form
* No Social Security
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02878694
Study Brief:
Protocol Section:
NCT02878694